Cargando…
Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice
OBJECTIVES: The results of the randomized phase 3 CREST trial evaluating the use of thoracic radiotherapy for extensive-stage small-cell lung cancer (ES-SCLC) were published in the Lancet in 2015. The primary endpoint (10% overall survival difference at 1-year) was not achieved, but there was signif...
Autores principales: | Haslett, Kate, De Ruysscher, Dirk, Dziadziuszko, Rafal, Guckenberger, Matthias, Pechoux, Cecile Le, Nestle, Ursula, Slotman, Ben, Faivre-Finn, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333293/ https://www.ncbi.nlm.nih.gov/pubmed/30196134 http://dx.doi.org/10.1016/j.ctarc.2018.08.004 |
Ejemplares similares
-
Evolving target volume concepts in locally advanced non-small cell lung cancer
por: Nestle, Ursula, et al.
Publicado: (2021) -
Thoracic radiotherapy in small cell lung cancer—a narrative review
por: Levy, Antonin, et al.
Publicado: (2021) -
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement()
por: Guckenberger, Matthias, et al.
Publicado: (2020) -
Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement
por: Guckenberger, Matthias, et al.
Publicado: (2020) -
Radiotherapy in thoracic malignancies: the preface
por: Jassem, Jacek, et al.
Publicado: (2021)